Gene One Life Science

Gene One Life Science EBIT per Share

The EBIT per Share of Gene One Life Science (011000.KS) as of Oct 26, 2026 is -13,697.71 KRW. In the previous year, EBIT per Share was -14,592.51 KRW — a change of -6.13% (higher).

EBIT per Share

-13,697.71KRW

YoY

-6.13%

Last updated:

EBIT per Share of Gene One Life Science is 2025 -13,697.71 KRW. EBIT per Share of Gene One Life Science was 2024 -14,592.51 KRW. It decreases by -6.13% higher compared to the previous year.

The Gene One Life Science EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-6,394.25 KRW
Jan 1, 2019
-4,910.27 KRW
Jan 1, 2020
-6,693.17 KRW
Jan 1, 2021
-9,801.62 KRW
Jan 1, 2022
-12,921.92 KRW
Jan 1, 2023
-24,428.22 KRW
Jan 1, 2024
-14,592.51 KRW
Jan 1, 2025
-13,697.71 KRW
The Gene One Life Science EBIT per Share history
YEAREBIT per ShareYoY
-13,697.71KRW-6.13%
-14,592.51KRW-40.26%
-24,428.22KRW+89.04%
-12,921.92KRW+31.83%
-9,801.62KRW+46.44%
-6,693.17KRW+36.31%
-4,910.27KRW-23.21%
-6,394.25KRW-68.31%
-20,175.00KRW+105.30%
-9,827.26KRW+261.88%
-2,715.60KRW-60.08%
-6,801.98KRW+7.02%
-6,355.55KRW-31.43%
-9,268.90KRW+66.99%
-5,550.64KRW+148.04%
-2,237.83KRW-77.70%
-10,037.02KRW-7.11%
-10,804.77KRW+10.92%
-9,741.25KRW+7,516.30%
-127.90KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gene One Life Science Stock analysis

What does Gene One Life Science do? GeneOne Life Science, Inc. generates revenue through its biomedical contract manufacturing organization (CMO) services, producing DNA vaccines for disease prevention and treatment. The company also sells wicks under the brand INTERON for use in dress shirts, suits, and caps, and provides biopharmaceutical services including research, development, and manufacturing of plasmid DNA and DNA vaccines. Its leasing business involves nonresidential buildings. The primary buyers for the biomedical CMO services are likely pharmaceutical companies seeking contract manufacturing for DNA vaccines. INTERON wicks are purchased by apparel manufacturers producing dress shirts, suits, and caps. The leasing segment targets commercial property tenants requiring nonresidential space. The company serves the biomedical, textile, and real estate sectors through these distinct business segments. Gene One Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gene One Life Science stock

EBIT per Share of Gene One Life Science is -13,697.71 KRW in 2025.

EBIT per Share of Gene One Life Science changed from -14,592.51 KRW to -13,697.71 KRW, representing a -6.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Gene One Life Science since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Gene One Life Science

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Gene One Life Science